Alzheimer’s

The AHEAD Study - with participants in the Orlando region - examines whether the newly approved drug lecanemab can prevent or at least delay the appearance of Alzheimer's symptoms.

Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young.

Facilitator Pamela Levin of the Alzheimer's Association said Art Connects ALZ is a relaxing program using watercolors . It's therapeutic but not art therapy or art instruction.

The FDA approved the use of Leqembi in January for patients with mild or early cases of dementia tied to Alzheimer’s. A year’s treatment runs about $26,500, and there are few options outside of self-pay.

The woman was unresponsive, and nurses were unable to detect her breathing. A state agency report found the facility "failed to ensure residents received dignified treatment and care at end of life."

The FDA overruled its own scientific advisers in approving Aduhelm, despite lack of proof that it met its promise of slowing patients' decline.

Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.

The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.

For husbands and wives across Florida, Alzheimer's disease tests their vows. Can they do the hard things?